Gisbert JP - Search Results

1

Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.

Nunes T, Etchevers MJ, Domènech E, García-Sánchez V, Ber Y, Peñalva M, Merino O, Nos P, Garcia-Planella E, Casbas AG, Esteve M, Taxonera Samsó C, Montoro Huguet M, Gisbert JP, Martín Arranz MD, García-Sepulcre MF, Barreiro-de Acosta M, Beltrán B, Alcaide Suárez N, Saro Gismera C, Cabriada JL, Cañas-Ventura A, Gomollón F, Panés J; Tobacco-Eneida Study Group of GETECCU. Nunes T, et al. Among authors: gisbert jp. Aliment Pharmacol Ther. 2013 Oct;38(7):752-60. doi: 10.1111/apt.12440. Epub 2013 Aug 26. Aliment Pharmacol Ther. 2013. PMID: 23980933 Free article.

2

[Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference].

Gisbert JP, Calvet X, Gomollón F, Sáinz R. Gisbert JP, et al. Med Clin (Barc). 2000 Feb 12;114(5):185-95. doi: 10.1016/s0025-7753(00)71237-1. Med Clin (Barc). 2000. PMID: 10738726 Review. Spanish. No abstract available.

3

[Pharmacological treatment of fistulae in Crohn's disease].

Gisbert JP, Gomollón F, Maté J, María Pajares J. Gisbert JP, et al. Med Clin (Barc). 2001 May 12;116(17):664-71. Med Clin (Barc). 2001. PMID: 11412666 Review. Spanish. No abstract available.

4

Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

Gisbert JP, Gomollón F, Maté J, Pajares JM. Gisbert JP, et al. Dig Dis Sci. 2002 Mar;47(3):471-88. doi: 10.1023/a:1017987229718. Dig Dis Sci. 2002. PMID: 11911332 No abstract available.

5

Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.

Vallve M, Vergara M, Gisbert JP, Calvet X. Vallve M, et al. Among authors: gisbert jp. Aliment Pharmacol Ther. 2002 Jun;16(6):1149-56. doi: 10.1046/j.1365-2036.2002.01270.x. Aliment Pharmacol Ther. 2002. PMID: 12030958 Free article.

6

[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].

Gisbert JP, Gomollón F, Maté J, Pajares JM. Gisbert JP, et al. Gastroenterol Hepatol. 2002 Jun-Jul;25(6):401-15. doi: 10.1016/s0210-5705(02)70275-6. Gastroenterol Hepatol. 2002. PMID: 12069704 Review. Spanish. No abstract available.

7

[Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity].

Gisbert JP, Gomollón F, Maté J, Pajares JM. Gisbert JP, et al. Rev Clin Esp. 2002 Oct;202(10):555-62. doi: 10.1016/s0014-2565(02)71143-0. Rev Clin Esp. 2002. PMID: 12361557 Review. Spanish. No abstract available.

8

[Treatment of stenosis due to Crohn's disease].

Gisbert JP, Gomollón F, Maté J, Figueroa JM, Alós R, Pajares JM. Gisbert JP, et al. Gastroenterol Hepatol. 2002 Nov;25(9):560-9. doi: 10.1016/s0210-5705(02)70313-0. Gastroenterol Hepatol. 2002. PMID: 12435308 Review. Spanish. No abstract available.

9

Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?

Gisbert JP, Jones EA, Pajares JM, Moreno-Otero R. Gisbert JP, et al. Aliment Pharmacol Ther. 2003 Jan;17(1):17-27. doi: 10.1046/j.1365-2036.2003.01381.x. Aliment Pharmacol Ther. 2003. PMID: 12492729 Free article. Review.

10

[The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].

Gisbert JP, Gomollón F, Maté J, Pajares JM. Gisbert JP, et al. Gastroenterol Hepatol. 2003 May;26(5):312-24. doi: 10.1016/s0210-5705(03)70365-3. Gastroenterol Hepatol. 2003. PMID: 12732107 Review. Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

895 results

Search Page